SCHEMBL19786739

SCHEMBL19786739

c1ccc(-c2ccc(-n3c4c5ccccc5ccc4c4c5c6ccccc6[nH]c5c5ccccc5c43)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRE P78334 1/20 0.44
GABRA6 Q16445 1/20 0.44
GABRG1 Q8N1C3 1/20 0.44
GABRG3 Q99928 1/20 0.44
GABRQ Q9UN88 1/20 0.44
CDK4 P11802 8/20 0.41
CCND1 P24385 8/20 0.41
CCNE2 O96020 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21432066 0.94 CDK4 (0.48) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL19786526 0.94 KIF11 (0.49) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL19786650 0.91 KIF11 (0.38) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL21432063 0.89 GABRP (0.40) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL21432053 0.88 KIF11 (0.46) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL19786530 0.86 KIF11 (0.42) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL21431934 0.86 ESR1 (0.42) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL21432051 0.85 KIF11 (0.43) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL19786740 0.84 CDK4 (0.40) KIF11GABRPGABRDGABRA1GABRB1
SCHEMBL19786651 0.82 CDK4 (0.36) KIF11GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KIF11 3699/4885GABRP 4122/4885GABRD 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.